Metabolic interactions of 1,3-butadiene and styrene in male B6C3F1 mice

Toxicology and Applied Pharmacology

Volumn 141, Issue 2, 1996, Pages 628-636

  Leavens, T L ^a,b,c   Moss, O R ^b   Turner, M J ^b   Janszen, D B ^b   Bond, J A ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; BUTADIENE DIEPOXIDE; STYRENE; STYRENE OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CHEMICAL INTERACTION; CONTROLLED STUDY; INHALATION; MALE; METABOLIC ACTIVATION; METABOLITE; MOUSE; NONHUMAN; TOXICOKINETICS; XENOBIOTIC METABOLISM;

EID: 0030448532     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0329     Document Type: Article

References (37)

1. Andersen, M. E. (1981). A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: Analysis at steady state. Toxicol. Appl. Pharmacol. 60, 509-526.
2. Boogaard, P. J., and Bond, J. A. (1996). The role of hydrolysis in the detoxication of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro. Toxicol. Appl. Pharmacol. 141, 617-628.
3. Boogaard, P., Sumner, S. C. J., and Bond, J. A. (1996). Glutathione conjugation of 1,2:3,4-diepoxybutane in human liver and rat and mouse liver and lung in vitro. Toxicol. Appl. Pharmacol. 136, 307-316.
4. Cochrane, H. E., and Skopek, T. R. (1994). Mutagenicity of butadiene and its epoxide metabolites: i. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 15, 713-717.
5. Csanády, G., Guengerich, F. P., and Bond, J. A. (1992). Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats, and mice. Carcinogenesis 13, 1143-1153.
6. Deutschmann, S., and Laib, R. J. (1989). Concentration-dependent depletion of non-protein sulfhydryl (NPSH) content in lung, heart, and liver tissue of rats and mice after acute inhalation exposure to butadiene. Toxicol. Lett. 45, 175-183.
7. Duescher, R. J., and Elfarra, A. A. (1994). Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: Evidence for major roles by cytochrome P450 2A6 and 2E1. Arch. Biochem. Biophys. 311, 342-349.
8. Fajen, J. M., Lunsford, R. A., and Roberts, D. R. (1993). Industrial exposure to 1,3-butadiene in monomer, polymer, and end-user industries. In Butadiene and Styrene: Assessment of Health Hazards, (M. Sorsa, K. Peltonen, H. Vainio, and K. Hemminki, Eds.), pp. 3-13. International Agency for Research on Cancer, Lyon.
9. Himmelstein, M. W., Acquavella, J. F., Recio, L., Medinsky, M. A., and Bond, J. A. (1996). Toxicology and epidemiology of 1,3-butadiene. CRC Rev. Toxicol., in press.
10. Himmelstein, M. W., Asgharian, B., and Bond, J. A. (1995). High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Toxicol. Appl. Pharmacol. 132, 281-288.
11. Himmelstein, M. W., Turner, M. J., Asgharian, B., and Bond, J. A. (1994). Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis 15, 1479-1486.
12. Jelitto, B., Vangala, R. R., and Laib, R. J. (1989). Species differences in DNA damage by butadiene: Role of diepoxybutane. Arch. Toxicol. Suppl. 13, 246-249.
13. Laib, R. J., Tucholski, M., Filser, J. G., and Csanady, G. A. (1992). Pharmacokinetic interaction between 1,3-butadiene and styrene in Sprague-Dawley rats. Arch. Toxicol. 66, 310-314.
14. Landry, T. D., Ramsey, J. C., and McKenna, M. J. (1983). Pulmonary physiology and inhalation dosimetry in rats: Development of a method and two examples. Toxicol. Appl. Pharmacol. 71, 72-83.
15. Langvardt, P. W., and Nolan, R. J. (1991). Determination of styrene-7,8-oxide in whole rat blood by gas chromatography - mass spectrometry. J. Chromatogr. 567, 93-103.
16. Leavens, T. L., Moss, O. R., and Bond, J. A. (1996). A dynamic inhalation system for individual whole-body exposure of mice to volatile organic chemicals. Inhal. Toxicol., 8, 655-677.
17. Leibman, K. (1975). Metabolism and toxicity of styrene. Environ. Health Perspect. 11, 115-119.
18. Löf, A., Gullstrand, E., Lundgren, E., and Nordqvist, M. B. (1984). Occurrence of styrene-7,8-oxide and styrene glycol in mouse after the administration of styrene. Scand. J. Work Environ. Health 10, 179-187.
19. Löf, A., Gullstrand, E., and Nordqvist, M. B. (1983). Tissue distribution of styrene, styrene glycol and more polar styrene metabolites in the mouse. Scand. J. Work Environ. Health 9, 419-430.
20. Malvoisin, E., Lhoest, G., Poncelet, F., Roberfroid, M., and Mercier, M. (1979). Identification and quantitation of 1,2-epoxybutene-3 as the primary metabolite of 1,3-butadiene. J. Chromatogr. 178, 419-425.
21. Malvoisin, E., Mercier, M., and Roberfroid, M. (1982). Enzymatic hydration of butadiene monoxide and its importance in the metabolism of butadiene. Adv. Exp. Med. Biol. 136A, 437-444.
22. Malvoisin, E., and Roberfroid, M. (1982). Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica 12, 137-144.
23. McConnell, E. E., and Swenberg, J. A. (1993). Styrene and styrene oxide: Results of studies on carcinogenicity in experimental animals. In Butadiene and Styrene: Assessment of Health Hazards (M. Sorsa, K. Peltonen, H. Vainio, and K. Hemminki, Eds.), pp. 323-334. International Agency for Research on Cancer, Lyon.
24. Medinsky, M. A., Leavens, T. L., Csanády, G. A., Gargas, M. L., and Bond, J. A. (1994). In vivo metabolism of butadiene by mice and rats: A comparison of physiological model predictions and experimental data. Carcinogenesis 15, 1329-1340.
25. Meinhardt, T. J., Lemen, R. A., Crandall, M. S., and Young, R. J. (1982). Environmental epidemiologic investigation of the styrene-butadiene rubber industry. Mortality patterns with discussion of the hematopoietic and lymphatic malignancies. Scand. J. Work Environ. Health 8, 250-259.
26. Meinhardt, T. J., Young, R. J., and Hartle, R. W. (1978). Epidemiologic investigations of styrene-butadiene rubber production and reinforced plastic production. Scand. J. Work Environ. Health 4(Suppl. 2), 240-246.
27. Melnick, R. L., Huff, J. E., Roycroft, J. H., Chou, B. J., and Miller, R. A. (1990). Inhalation toxicology and carcinogenicity of 1,3-butadiene in B6C3F1 mice following 65 weeks of exposure. Environ. Health Perspect. 86, 27-36.
28. Nakajima, T., Elovaara, E., Gonzalez, F. J., Gelboin, H. V., Raunio, H., Pelkonen, O., Vainio, H., and Aoyama, T. (1994a). Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chem. Res. Toxicol. 7, 891-896.
29. Nakajima, T., Wang, R.-S., Elovaara, E., Gonzalez, F. J., Gelboin, H. V., Vainio, H., and Aoyama, T. (1994b). Cyp2C11 and Cyp2B1 are major cytochrome P450 forms involved in styrene oxidation in liver and lung microsomes from untreated rats, respectively. Biochem. Pharmacol. 48, 637-642.
30. 13C]butadiene. Chem. Res. Toxicol. 9, 764-773.
31. Norppa, H., and Sorsa, M. (1993). Genetic toxicity of 1,3-butadiene and styrene. In Butadiene and Styrene: Assessment of Health Hazards (M. Sorsa, K. Peltonen, H. Vainio, and K. Hemminki, Eds.), pp. 185-193. International Agency for Research on Cancer, Lyon.
32. Owen, P. E., and Glaister, J. R. (1990). Inhalation toxicity and carcinogenicity of 1,3-butadiene in Sprague-Dawley rats. Environ. Health Perspect. 86, 19-25.
33. Ramsey, J. C., and Andersen, M. E. (1984). A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73, 159-175.
34. Sabourin, P. J., Burka, L. T., Bechtold, W. E., Dahl, A. R., Hoover, M. D., Chang, I. Y., and Henderson, R. F. (1992). Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4-(N-acetylcysteinyl)butane, a novel metabolite of butadiene. Carcinogenesis 13, 1633-1638.
35. Seaton, M. J., Follansbee, M. H., and Bond, J. A. (1995). Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 16, 2287-2293.
36. Sumner, S. J., and Fennell, T. R. (1994). Review of the metabolic fate of styrene. CRC Rev. Toxicol. 24(S1), S11-S33.
37. Thornton-Manning, J. R., Dahl, A. R., Bechtold, W. E., Griffith, W. C., and Henderson, R. F. (1995). Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 16, 1723-1731.